Published in Anal Biochem on October 01, 1996
Drug delivery by red blood cells: vascular carriers designed by mother nature. Expert Opin Drug Deliv (2010) 1.30
Human complement receptor type 1-directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysis. Blood (2006) 1.11
Advanced drug delivery systems for antithrombotic agents. Blood (2013) 0.92
In vitro and in vivo degradation of Abeta peptide by peptidases coupled to erythrocytes. Peptides (2007) 0.88
Soluble urokinase receptor conjugated to carrier red blood cells binds latent pro-urokinase and alters its functional profile. J Control Release (2009) 0.88
Delivery of drugs bound to erythrocytes: new avenues for an old intravascular carrier. Ther Deliv (2015) 0.81
Deep-coverage rhesus red blood cell proteome: a first comparison with the human and mouse red blood cell. Blood Transfus (2010) 0.80
The Effect of Polymeric Nanoparticles on Biocompatibility of Carrier Red Blood Cells. PLoS One (2016) 0.78
Antigens protected functional red blood cells by the membrane grafting of compact hyperbranched polyglycerols. J Vis Exp (2013) 0.78
Self-propelled Leidenfrost droplets. Phys Rev Lett (2006) 2.36
Improved immunoturbidimetric assay for cystatin C. Ann Clin Biochem (2001) 2.09
Glycated haemoglobin: an assessment of high capacity liquid chromatographic and immunoassay methods. Ann Clin Biochem (1992) 1.78
Inhibition of lung surfactant protein B expression during Pneumocystis carinii pneumonia in mice. J Lab Clin Med (1999) 1.58
Physiological and pathological aspects of circulating immune complexes. Kidney Int (1989) 1.57
Clinical usefulness of cystatin C for the estimation of glomerular filtration rate in type 1 diabetes: reproducibility and accuracy compared with standard measures and iohexol clearance. Diabetes Care (2002) 1.39
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. J Clin Invest (1995) 1.24
Antibodies to DNA. A perspective. Arthritis Rheum (1986) 1.24
Decreased complement mediated binding of antibody/3H-dsDNA immune complexes to the red blood cells of patients with systemic lupus erythematosus, rheumatoid arthritis, and hematologic malignancies. Arthritis Rheum (1983) 1.19
Antibodies to Sm in patients with systemic lupus erythematosus. Correlation of Sm antibody titers with disease activity and other laboratory parameters. Arthritis Rheum (1981) 1.16
Aspergillus fumigatus-induced allergic airway inflammation alters surfactant homeostasis and lung function in BALB/c mice. Am J Respir Cell Mol Biol (2001) 1.15
An autonomous surgical robot for drilling a cochleostomy: preliminary porcine trial. Clin Otolaryngol (2008) 1.10
Bispecific monoclonal antibodies mediate binding of dengue virus to erythrocytes in a monkey model of passive viremia. J Immunol (2001) 1.07
Mouse model of microembolic stroke and reperfusion. Stroke (2004) 1.05
Clearance of human antibody/DNA immune complexes and free DNA from the circulation of the nonhuman primate. Clin Immunol Immunopathol (1987) 1.04
Immunotargeting of antioxidant enzyme to the pulmonary endothelium. Proc Natl Acad Sci U S A (1996) 1.03
Heteropolymer-mediated clearance of immune complexes via erythrocyte CR1: mechanisms and applications. Immunol Rev (2001) 1.03
DNA/anti-DNA complexes: correlation of size and complement fixation. Arthritis Rheum (1981) 1.02
In vivo and in vitro studies of the binding of antibody/dsDNA immune complexes to rabbit and guinea pig platelets. J Immunol (1985) 1.01
Detection of low avidity anti-DNA antibodies in systemic lupus erythematosus. Arthritis Rheum (1979) 1.01
Stability of DNA/anti-DNA complexes. II. Salt lability and avidity. J Immunol (1980) 0.98
The kinetics of [3H]-dsDNA/anti-DNA immune complex formation, binding by red blood cells, and release into serum: effect of DNA molecular weight and conditions of antibody excess. J Immunol (1984) 0.97
In vivo handling of soluble complement fixing Ab/dsDNA immune complexes in chimpanzees. J Clin Invest (1989) 0.97
Cell-selective intracellular delivery of a foreign enzyme to endothelium in vivo using vascular immunotargeting. FASEB J (2001) 0.95
How are immune complexes bound to the primate erythrocyte complement receptor transferred to acceptor phagocytic cells? Mol Immunol (2000) 0.95
Urokinase mediates fibrinolysis in the pulmonary microvasculature. Blood (2000) 0.95
Quantitative analyses of the binding of soluble complement-fixing antibody/dsDNA immune complexes to CR1 on human red blood cells. J Immunol (1987) 0.95
Rapid immune adherence reactivity of nascent, soluble antibody/DNA immune complexes in the circulation. J Immunol (1987) 0.94
Studies on the kinetics of binding of complement-fixing dsDNA/anti-dsDNA immune complexes to the red blood cells of normal individuals and patients with systemic lupus erythematosus. Arthritis Rheum (1984) 0.93
Dynamics of interaction between complement-fixing antibody/dsDNA immune complexes and erythrocytes. In vitro studies and potential general applications to clinical immune complex testing. J Clin Invest (1985) 0.92
Quantitative analyses of the relationship between C3 consumption, C3b capture, and immune adherence of complement-fixing antibody/DNA immune complexes. J Immunol (1988) 0.91
Studies of the physical biochemistry and complement-fixing properties of DNA/anti-DNA immune complexes. J Immunol (1981) 0.91
A comparison of three methods for the estimation of capillary blood glucose in filter paper spots. Ann Clin Biochem (1982) 0.90
Targeting of Pseudomonas aeruginosa in the bloodstream with bispecific monoclonal antibodies. J Immunol (2001) 0.90
Endothelial cells internalize monoclonal antibody to angiotensin-converting enzyme. Am J Physiol (1996) 0.90
Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism. Arthritis Rheum (2000) 0.90
A surgical robot for cochleostomy. Conf Proc IEEE Eng Med Biol Soc (2007) 0.89
Enzymatic and colorimetric determination of total serum cholesterol. An undergraduate biochemistry laboratory experiment. J Chem Educ (1978) 0.89
Endotoxin reduces specific pulmonary uptake of radiolabeled monoclonal antibody to angiotensin-converting enzyme. J Nucl Med (1991) 0.88
The complement-mediated binding of soluble antibody/dsDNA immune complexes to human neutrophils. J Immunol (1983) 0.88
Control of conformation of -chymotrypsin through chemical modification. Biochemistry (1973) 0.88
Enhanced tumour specificity of an anti-carcinoembrionic antigen Fab' fragment by poly(ethylene glycol) (PEG) modification. Br J Cancer (1996) 0.88
Stability of DNA/ANTI-DNA complexes. IV. Complement fixation. J Immunol Methods (1980) 0.87
Validity of simplified protocols to estimate glomerular filtration rate using iohexol clearance. Ann Clin Biochem (2007) 0.87
Transfer of immune complexes from erythrocyte CR1 to mouse macrophages. J Immunol (2000) 0.86
Quantitative determination of anti-dsDNA antibodies and antibody/dsDNA stoichiometries in prepared, soluble complement-fixing antibody/dsDNA immune complexes. Mol Immunol (1984) 0.86
Artistic forms and complexity. Nonlinear Dynamics Psychol Life Sci (2011) 0.85
Extracorporeal life support for severe pediatric respiratory failure: an updated experience 1991-1993. J Pediatr (1994) 0.84
Targeting of antibody-conjugated plasminogen activators to the pulmonary vasculature. J Pharmacol Exp Ther (1996) 0.84
Lung is the target organ for a monoclonal antibody to angiotensin-converting enzyme. Lab Invest (1991) 0.84
Suramin inhibits the binding of complement-fixing antibody/double-stranded DNA immune complexes to CR1. Clin Immunol Immunopathol (1984) 0.84
A smart micro-drill for cochleostomy formation: a comparison of cochlear disturbances with manual drilling and a human trial. Cochlear Implants Int (2011) 0.84
Simple biochemical markers to assess chronic wounds. Wound Repair Regen (2000) 0.84
Immune adherence and the processing of soluble complement-fixing antibody/DNA immune complexes in mice. Clin Immunol Immunopathol (1989) 0.83
A new method for quantification of islets by measurement of zinc content. Diabetes (1992) 0.83
Cross-linked bispecific monoclonal antibody heteropolymers facilitate the clearance of human IgM from the circulation of squirrel monkeys. Eur J Immunol (1994) 0.83
Escherichia coli bound to the primate erythrocyte complement receptor via bispecific monoclonal antibodies are transferred to and phagocytosed by human monocytes in an in vitro model. J Immunol (1998) 0.83
Free plasma DNA in patients with pulmonary embolism. South Med J (1980) 0.83
The effect of hallux abducto valgus surgery on the sesamoid apparatus position. J Am Podiatr Med Assoc (2000) 0.83
Bovine serum albumin as catalyst. III. Conformational studies. J Am Chem Soc (1975) 0.82
Stability of DNA/anti-DNA complexes. J Immunol (1979) 0.82
Antigens pre-bound to the primate erythrocyte complement receptor via cross-linked bispecific monoclonal antibody heteropolymers are rapidly cleared from the circulation. Eur J Immunol (1993) 0.82
Quantitative aspects of lupus anti-DNA autoantibody specificity. J Immunol (1986) 0.82
Infusion of bispecific monoclonal antibody complexes into monkeys provides immunologic protection against later challenge with a model pathogen. Clin Immunol (1999) 0.82
Attachment of antibody to biotinylated red blood cells: immuno-red blood cells display high affinity to immobilized antigen and normal biodistribution in rats. Biotechnol Appl Biochem (1996) 0.81
Functional characterization of non-human primate erythrocyte immune adherence receptors: implications for the uptake of immune complexes by the cells of the mononuclear phagocytic system. Eur J Immunol (1992) 0.81
Establishing predictive indicators for the status of loaded soft tissues. J Appl Physiol (1985) (2001) 0.81
The functional effects of biotinylation of anti-angiotensin-converting enzyme monoclonal antibody in terms of targeting in vivo. Anal Biochem (1995) 0.81
A polyethylene glycol radioimmunoprecipitation assay for human immunoglobulin G. J Immunol Methods (1979) 0.80
The kinetics of clearance of human antibody/dsDNA immune complexes from rabbit circulation. Effects of dsDNA size, rheumatoid factor, and reduction and alkylation of the antibodies. J Immunol (1986) 0.80
Stability of DNA/anti-DNA complexes. III. Kinetic control of immune complex size. J Immunol (1980) 0.80
Complement-independent binding of microorganisms to primate erythrocytes in vitro by cross-linked monoclonal antibodies via complement receptor 1. Infect Immun (1995) 0.80
Nature of double-stranded DNA binding activity in seropositive rheumatoid arthritis: formation of low avidity DNA/rheumatoid factor/IgG/low density lipoprotein complexes. J Immunol (1981) 0.79
Nuclear magnetic resonance studies of amphiphile hydration. Effects of the gel-to-liquid crystalline phase transition on the hydration of dioleoyl lecithin. Arch Biochem Biophys (1978) 0.79
Measurement of blood flow by angiography with increasing rate of injection: experimental study. Invest Radiol (1971) 0.79
Reversible quantum brownian heat engines for electrons. Phys Rev Lett (2002) 0.79
Bovine serum albumin as a catalyst. Accelerated decomposition of a Meisenheimer complex. J Am Chem Soc (1973) 0.78
A bispecific dsDNAxmonoclonal antibody construct for clearance of anti-dsDNA IgG in systemic lupus erythematosus. J Immunol Methods (2001) 0.78
Immunotargeting of streptavidin to the pulmonary endothelium. J Nucl Med (1994) 0.78
Antioxidant characteristics of chronic wound fluid. Br J Dermatol (2001) 0.78
[Serum angiotensin converting enzyme in the diagnosis of sarcoidosis and other lung diseases]. Probl Tuberk (1991) 0.78
Interaction between rheumatoid factor and antibody/DNA complexes: enhancement of complement fixation. Arthritis Rheum (1981) 0.78
Quantitative analyses of complement fixation in three immune complex systems. Immunology (1984) 0.78
Targeting of cancer cells with monoclonal antibodies specific for C3b(i). Cancer Immunol Immunother (2000) 0.78
Antigen-based heteropolymers. A potential therapy for binding and clearing autoantibodies via erythrocyte CR1. Arthritis Rheum (1995) 0.78
Impact of small-angle scattering on ballistic transport in quantum dots. Phys Rev Lett (2012) 0.77
Antigen-based heteropolymers facilitate, via primate erythrocyte complement receptor type 1, rapid erythrocyte binding of an autoantibody and its clearance from the circulation in rhesus monkeys. J Immunol (1995) 0.77
Quantitative studies of the interaction of 3H-dsDNA/anti-DNA immune complexes with complement: comparison and evaluation of the Raji cell, the solution phase C1Q, and the red blood cell linked complement fixation radioimmunoassays. Rheumatol Int (1981) 0.77
Comparison of Bayer Advia Centaur immunoassay results obtained on samples collected in four different Becton Dickinson Vacutainer tubes. Ann Clin Biochem (2006) 0.77
Human anti-endotoxin antibody HA-1A mediates complement-dependent binding of Escherichia coli J5 lipopolysaccharide to complement receptor type 1 of human erythrocytes and neutrophils. J Infect Dis (1993) 0.77
Attachment of biotinylated antibody to red blood cells: antigen-binding capacity of immunoerythrocytes and their susceptibility to lysis by complement. Anal Biochem (1994) 0.77
Preparation of monoclonal antibodies to C3b by immunization with C3b(i)-sepharose. J Immunol Methods (1989) 0.77
Complement-component-C3-opsonized immunoglobulin G anti-DNA antibodies do not bind effectively to red blood cells unless aggregated on a high-Mr DNA matrix. Biochem J (1984) 0.77
Use of fresh frozen plasma to enhance the therapeutic action of rituximab. QJM (2008) 0.77
Quantitative studies of heteropolymer-mediated binding of inactivated Marburg virus to the complement receptor on primate erythrocytes. J Immunol Methods (1998) 0.77
The art and science of hyperbolic tessellations. Nonlinear Dynamics Psychol Life Sci (2013) 0.77